Literature DB >> 1867173

Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective.

J C Jennette1.   

Abstract

Antineutrophil cytoplasmic autoantibodies (ANCA) are a useful diagnostic serologic marker for the most common forms of necrotizing vasculitis, provide a means of categorizing vasculitides so that diagnostically useful shared pathologic and clinical characteristics can be recognized, and offer insight into the pathogenesis of previously idiopathic diseases. ANCA-associated vasculitides can be categorized into a number of distinctive clinicopathologic categories, eg, Wegener's granulomatosis, Churg-Strauss syndrome, pulmonary renal syndrome, microscopic polyarteritis nodosa, leukocytoclastic angiitis, and necrotizing and crescentic glomerulonephritis. At least the latter four syndromes can also be caused by other ANCA-negative immunopathogenic mechanisms, eg, immune complex deposition. Therefore, thorough diagnostic classification requires both an assessment of clinicopathologic category, as well as an assessment of immunopathologic category. Although different ANCA-associated vasculitic syndromes have distinctive clinical and pathologic features, all ANCA-associated vasculitides share a number of common pathologic features, ie, focal distribution, necrosis, and neutrophil infiltration. ANCA assays have very good sensitivity and specificity for ANCA-associated diseases, but the prevalence of these diseases in the patient population being analyzed must be taken into consideration when determining the predictive value of a test result. As with all serologic tests, ANCA results must be integrated with other clinical and pathologic data in order to reach the most accurate diagnostic conclusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867173     DOI: 10.1016/s0272-6386(12)80874-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  [Vasculitides: classification, clinical aspects and pathology. A review].

Authors:  Peter Meister
Journal:  Pathologe       Date:  2003-04-08       Impact factor: 1.011

3.  Anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel diseases (IBD).

Authors:  T Nakato; M Fukushima; H Yamamoto
Journal:  Gastroenterol Jpn       Date:  1992-10

Review 4.  Renal involvement in primary vasculitides.

Authors:  R A Sinico; G D'Amico
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  ANCA associated pauci-immune retinal vasculitis.

Authors:  M J Gallagher; K G-J Ooi; M Thomas; M Gavin
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 6.  Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies?

Authors:  J C Jennette; R J Falk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

7.  Detection of autoantibodies to neutrophil cytoplasmic antigens.

Authors:  J Savige
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

8.  Elevated serum levels of two anti-neutrophil cytoplasmic antibodies in a lung cancer patient: A case report.

Authors:  Shinichiro Okauchi; Tomohiro Tamura; Katsunori Kagohashi; Mio Kawaguchi; Hiroaki Satoh
Journal:  Biomed Rep       Date:  2016-09-06

9.  Anti-neutrophil cytoplasmic auto-antibodies-associated vasculitis with pulmonary and renal involvement.

Authors:  G Pintos-Morell; A Roca-Comas; M A Naranjo; C Tural; E Abad; G Javier; J Prats
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

10.  Anti-proteinase 3 antibodies, their characterization and disease associations.

Authors:  J G Jennings; L Chang; J A Savige
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.